cytidine has been researched along with Carcinoma, Ductal, Pancreatic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Feng, Z; Han, D; Jiang, L; Li, K; Liang, H; Liang, J; Ma, Y; Peng, C; Qin, K; Shen, B; Shi, M; Zhao, S | 1 |
| Bhutkar, S; Dukhande, V; Patel, K; Patki, M; Saraswat, A | 1 |
2 other study(ies) available for cytidine and Carcinoma, Ductal, Pancreatic
| Article | Year |
|---|---|
The LINC00623/NAT10 signaling axis promotes pancreatic cancer progression by remodeling ac4C modification of mRNA.
Topics: Acetyltransferases; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cytidine; Gene Expression Regulation, Neoplastic; Humans; N-Terminal Acetyltransferases; Neoplasm Invasiveness; Pancreatic Neoplasms; RNA, Long Noncoding; RNA, Messenger; Ubiquitin-Specific Proteases | 2022 |
In vitro assessment of a synergistic combination of gemcitabine and zebularine in pancreatic cancer cells.
Topics: Antimetabolites, Antineoplastic; Apoptosis Regulatory Proteins; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cytidine; Cytidine Deaminase; Deoxycytidine; Gemcitabine; Humans; Pancreas; Pancreatic Neoplasms | 2021 |